SNGX earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -0.18. Updated 2026-07-23.
Soligenix (SNGX) Research Hub
Soligenix (SNGX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.3501 USD (-4.08%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.18, market cap 0.00B. This hub links to the full technical, earnings and options research available for SNGX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.3501 USD (-4.08%) |
| 52-week range | 0.3248 USD – 0.45 USD |
| Trend regime | Range |
| 14-day RSI | 47.1 (Neutral) |
| Trailing P/E | -0.18 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for SNGX
Covered Call on SNGX: how it works, illustrative setup around the real 0.3501 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SNGX: how it works, illustrative setup around the real 0.3501 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SNGX: how it works, illustrative setup around the real 0.3501 USD price, max profit/loss, breakeven and when to use it. Educational.
SNGX technical analysis: range, last 0.3501 USD, RSI 47.1, 52w range 0.3248 USD–0.45 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SNGX in?
Soligenix (SNGX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SNGX in an uptrend or downtrend?
As of 2026-10-26, SNGX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SNGX's trailing P/E ratio?
SNGX's trailing P/E is -0.18, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does SNGX next report earnings?
SNGX is next scheduled to report earnings on 2026-08-13.